140 related articles for article (PubMed ID: 35496040)
1. Expression of Matrix Metalloproteinase-7 Predicts Poor Prognosis in Gastric Cancer.
Wattanawongdon W; Bartpho TS; Tongtawee T
Biomed Res Int; 2022; 2022():2300979. PubMed ID: 35496040
[TBL] [Abstract][Full Text] [Related]
2. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
3. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Zhang Q; Wang P; Shao M; Chen SW; Xu ZF; Xu F; Yang ZY; Liu BY; Gu QL; Zhang WJ; Li Y
Tumori; 2015; 101(5):566-71. PubMed ID: 26350198
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Long ZW; Wang JL; Wang YN
Tumour Biol; 2014 Nov; 35(11):11415-26. PubMed ID: 25123263
[TBL] [Abstract][Full Text] [Related]
7. The mouse double minute 2 polymorphism is associated with both decreased p53 expression and poor clinicopathological outcomes of gastric cancer.
Bartpho TS; Wattanawongdon W; Tongtawee T
J Cancer Res Ther; 2021; 17(6):1438-1445. PubMed ID: 34916375
[TBL] [Abstract][Full Text] [Related]
8. Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer.
Wu T; Li Y; Lu J; Qiao Q; Bao G; Wang N; He X; Du X
Med Oncol; 2013 Mar; 30(1):323. PubMed ID: 23275114
[TBL] [Abstract][Full Text] [Related]
9. Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB).
Kesh K; Subramanian L; Ghosh N; Gupta V; Gupta A; Bhattacharya S; Mahapatra NR; Swarnakar S
J Biol Chem; 2015 Jun; 290(23):14391-406. PubMed ID: 25847246
[TBL] [Abstract][Full Text] [Related]
10. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
12. Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer.
Liu YF; Guo S; Zhao R; Chen YG; Wang XQ; Xu KS
World J Surg; 2012 Jan; 36(1):109-17. PubMed ID: 21773953
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Liu XP; Kawauchi S; Oga A; Tsushimi K; Tsushimi M; Furuya T; Sasaki K
Jpn J Cancer Res; 2002 Mar; 93(3):291-5. PubMed ID: 11927011
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
[TBL] [Abstract][Full Text] [Related]
15. New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee.
Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fushida S; Fujimura T; Ohira M; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
Gastric Cancer; 2015 Jan; 18(1):119-28. PubMed ID: 24488015
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
Li L; Zhang S; Lin H; Lin JY
Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
18. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
20. The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis.
Song YX; Zhou X; Wang ZN; Gao P; Li AL; Liang JW; Zhu JL; Xu YY; Xu HM
PLoS One; 2012; 7(5):e38002. PubMed ID: 22655095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
